Compositions and methods for the modification of gene expression
View Patent ↗Novel isolated vascular tissue-specific plant polynucleotide promoter sequences are provided, together with genetic constructs comprising such polynucleotides. Methods for using such constructs in modulating the transcription of DNA sequences of interest are also disclosed, together with transgenic plants comprising such constructs.
1. An isolated polynucleotide comprising the sequence of nucleotides 1525-1643 of SEQ ID NO: 113 comprising a functional vascular tissue-specific E. grandis cOMT promoter.
2. The isolated polynucleotide of claim 1 , wherein the polynucleotide comprises the sequence selected from the group consisting of SEQ ID NO: 12, SEQ ID NO: 60, nucleotides 1-1643 of SEQ ID NO: 113, nucleotides 1019-1643 of SEQ ID NO: 113, nucleotides 1351-1643 of SEQ ID NO: 113, nucleotides 1338-1643 of SEQ ID NO: 113; nucleotides 1159-1643 of SEQ ID NO: 113; and nucleotides 1110-1643 of SEQ ID NO: 113.
3. The isolated polynucleotide of claim 1 , wherein the polynucleotide comprises the sequence of SEQ ID NO: 113.
4. A genetic construct comprising a polynucleotide sequence of any one of claims 1 - 3 .
5. A genetic construct comprising, in the 5′-3′ direction:
(a) a promoter sequence;
(b) a DNA sequence of interest; and
(c) a gene termination sequence,
wherein the promoter sequence comprises a polynucleotide sequence of claim 1 or claim 2 ;
wherein said promoter sequence possesses vascular tissue-specific promoter function of the E.grandis cOMT gene.
6. The genetic construct of claim 5 , wherein the DNA sequence of interest is operably linked to the promoter in an antisense orientation.
7. The genetic construct of claim 5 , wherein the DNA sequence of interest is a coding sequence operably linked to the promoter in a sense orientation.
8. The genetic construct of claim 5 , wherein the DNA sequence of interest is a RNAi expression construct.
9. The genetic construct of claim 5 , wherein the DNA sequence of interest comprises a non-coding sequence operably linked to the promoter in a sense orientation.
10. A genetic construct comprising in the 5′-3′ direction:
(a) a promoter sequence;
(b) a polynucleotide sequence of any one of claims 1 - 3 ; and
(c) a gene termination sequence,
wherein the promoter sequence in (a) comprises a xylem-specific promoter sequence that is different from the polynucleotide sequence of (b).
11. A genetic construct comprising in the 5′-3′ direction:
(a) a promoter sequence;
(b) a polynucleotide sequence comprising the sequence of nucleotides 1525-1643 of SEQ ID NO: 113 inserted in said construct as a direct or inverted repeat; and
(c) a gene termination sequence,
wherein the promoter sequence in (a) comprises a xylem-specific promoter sequence that is different from the polynucleotide sequence of (b).
12. A host cell comprising the genetic construct of claim 4 .
13. The host cell of claim 12 , wherein the host cell is a plant cell.
14. A method for identifying a gene responsible for a desired function or phenotype, comprising:
(a) transforming a plant cell with the genetic construct of claim 5 , wherein said DNA sequence of interest comprises said gene;
(b) cultivating the plant cell under conditions conducive to regeneration and mature plant growth to provide a transgenic plant in which the gene is expressed; and
(c) comparing the phenotype of the transgenic plant with the phenotype of a non-transformed plant, wherein said transgenic plant possesses the desired phenotype resulting from a change in lignification as compared to said non-transformed plant.
15. The method of claim 14 , wherein said lignification is reduced in said transgenic plant as compared to said non-transformed plant.
16. The method of claim 14 , wherein said promoter sequence directs transcription of said DNA sequence of interest in xylem or a tissue involved in xylogenesis of said transgenic plant.
17. An isolated polynucleotide sequence comprising a sequence selected from the group consisting of:
a polynucleotide comprising a 180-mer, a 220-mer, a 250-mer, a 300-mer, 400-mer, 500-mer or 600-mer complementary to SEQ ID NO: 12, SEQ ID NO: 60, or nucleotides 1-1643 of SEQ ID NO: 113.
18. An isolated polynucleotide sequence comprising a sequence selected from the group consisting of:
a polynucleotide comprising a 180-mer, a 220-mer, a 250-mer, a 300-mer, 400-mer, 500-mer or 600-mer of SEQ ID NO: 113.
19. A genetic construct comprising in the 5′-3′ direction:
(a) a promoter sequence;
(b) a polynucleotide sequence of claim 17 ; and
(c) a gene termination sequence.